Austrian based lab consolidator, Lifebrain, has sold its Swiss labs to Synlab and will now focus entirely on the fragmented Italian market, says CEO Dr Michael Havel. Having bought 100 labs in the last 12 months, he claims to have 50 more in the pipeline, and expects EBITDA margins of 30% on sales of €135m by 2017.